Professional Seasonal Analysis for Trading

Allarity Therapeutics, Inc. - Common stock (ALLR)

Seasonality Analysis

Stocks 5 Years Analyzed

Allarity Therapeutics, Inc. - Common stock Annual Seasonality Statistics

-220.07%
Avg Annual Return
22.1%
Avg Monthly Win Rate
1/12
Positive Months
5
Years Analyzed

Allarity Therapeutics, Inc. - Common stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -11.53%
20%
Very Weak
February -23.82%
20%
Very Weak
March -26.22%
40%
Weak
April -27.77%
40%
Weak
May -6.36%
25%
Very Weak
June WORST -33.74%
25%
Very Weak
July -21.80%
0%
Very Weak
August BEST 6.37%
50%
Weak
September -29.03%
0%
Very Weak
October -26.20%
0%
Very Weak
November -10.15%
25%
Very Weak
December -9.83%
20%
Very Weak

Allarity Therapeutics, Inc. - Common stock 2026 vs Historical Pattern

Current Position
70.37
Historical Avg Position
13.67
Deviation
+56.7
Performance
Significantly Above Average

Allarity Therapeutics, Inc. - Common stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ALLR with overlay patterns, custom date ranges, and more.

Create Free Account

Allarity Therapeutics, Inc. - Common stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Allarity Therapeutics, Inc. - Common stock Seasonal Historical Performance

Historical Performance

See historical average returns for ALLR across multiple timeframes.

Create Free Account

About Allarity Therapeutics, Inc. - Common stock (ALLR) Seasonality

Allarity Therapeutics, Inc. - Common stock (ALLR) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Allarity Therapeutics, Inc. - Common stock shows distinct seasonal tendencies based on historical data.

The strongest month for Allarity Therapeutics, Inc. - Common stock is historically August, with an average return of 6.37% and a win rate of 50%. Conversely, June tends to be the weakest month, averaging -33.74% return.

Looking at the full calendar year, Allarity Therapeutics, Inc. - Common stock has an average annual return of -220.07% with an overall monthly win rate of 22.1%. Out of 12 months, 1 typically show positive average returns.

The seasonal pattern for Allarity Therapeutics, Inc. - Common stock has a consistency score of 68.5 (Good), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Allarity Therapeutics, Inc. - Common stock Seasonality FAQ

What is the best month to buy Allarity Therapeutics, Inc. - Common stock (ALLR)?

Historically, August has been the best month for Allarity Therapeutics, Inc. - Common stock, with an average return of 6.37% and a win rate of 50%. However, past performance does not guarantee future results.

What is the worst month for Allarity Therapeutics, Inc. - Common stock (ALLR)?

Based on historical data, June has been the weakest month for Allarity Therapeutics, Inc. - Common stock, with an average return of -33.74%. This is a historical observation and does not guarantee future results.

How reliable is ALLR seasonality data?

The seasonality analysis for Allarity Therapeutics, Inc. - Common stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Allarity Therapeutics, Inc. - Common stock seasonality in my trading?

Use Allarity Therapeutics, Inc. - Common stock (ALLR) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.